AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 1421271-01-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 1421271-01-3
Also known as: 1421271-01-3, Starbld0026941, Cs-0147468, Sodium =(6s)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate
Molecular Formula
C8H7N2NaO3
Molecular Weight
202.14  g/mol
InChI Key
LRRYFHNJQIJOSH-JEDNCBNOSA-M

1 2D Structure

CAS 1421271-01-3

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;(6S)-4-oxo-7,8-dihydro-6H-pyrrolo[1,2-a]pyrimidine-6-carboxylate
2.1.2 InChI
InChI=1S/C8H8N2O3.Na/c11-7-3-4-9-6-2-1-5(8(12)13)10(6)7;/h3-5H,1-2H2,(H,12,13);/q;+1/p-1/t5-;/m0./s1
2.1.3 InChI Key
LRRYFHNJQIJOSH-JEDNCBNOSA-M
2.1.4 Canonical SMILES
C1CC2=NC=CC(=O)N2C1C(=O)[O-].[Na+]
2.1.5 Isomeric SMILES
C1CC2=NC=CC(=O)N2[C@@H]1C(=O)[O-].[Na+]
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 1421271-01-3

2. Starbld0026941

3. Cs-0147468

4. Sodium =(6s)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate

2.3 Create Date
2016-11-21
3 Chemical and Physical Properties
Molecular Weight 202.14 g/mol
Molecular Formula C8H7N2NaO3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area72.8
Heavy Atom Count14
Formal Charge0
Complexity338
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Flag China
Digital Content Digital Content
URL Supplier Web Content
1421271-01-3
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY